affected by daily dosage, with higher doses imparting greater risk of side effects. We conditionally recommend the addition of HCQ to prophylactic-dose heparin or LMWH and low-dose aspirin therapy for patients with primary APS. Recent small studies of APS pregnancies suggest that HCQ may decrease complications In pregnant women with positive aPL who do not meet criteria for APS and do not have another indication for the drug (such as SLE), we conditionally recommend against treating with